Published date: 5 November 2018

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 7 August 2017

Contract summary

Industry

  • Antivirals for systemic use - 33651400

Location of contract

Any region, Scotland, Wales, Northern Ireland, Isle of Man, Channel Islands

Value of contract

£0

Procurement reference

CM/EMI/16/5505

Published date

5 November 2018

Closing date

7 August 2017

Contract start date

16 April 2018

Contract end date

15 March 2022

Contract type

Supply contract

Procedure type

Competitive procedure with negotiation (above threshold)

Anyone may ask to participate, but only those who are pre-selected will be invited to submit initial tenders and to negotiate.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

This procurement exercise may result in one or more contracts for the provision of antivirals for use in an influenza pandemic, or a wide scale epidemic. The Authority will use any resulting contracts to maintain astockpile of products in the range of 23-38m treatment courses across all 4 lots.

The period of the contract is for four years with up to three 12 month extension options. The contract start/end date within this notice is a guide only.

More information

Previous notice about this procurement

Antivirals for use in an influenza pandemic, or wide scale epidemic

  • Opportunity
  • Published 7 July 2017

Attachments

Award information

Awarded date

20 September 2018

Contract start date

21 September 2018

Contract end date

30 September 2021

Total value of contract

£0

This contract was awarded to 2 suppliers.

GLAXOSMITHKLINE UK LIMITED

Address

G S K House,980 Great West Road
BRENTFORD
Middlesex
TW8 9GS
GB

Reference

Companies House number: 04310159

Value of contract

£0

Supplier is SME?

No

Supplier is VCSE?

No

Additional details

Zanamivir Inhalers for the Treatment of Patients Aged 5 Years and Over

ROCHE PRODUCTS LIMITED

Address

6 Falcon Way, Shire Park
AL7 1TW
GB

Reference

Companies House number: 00100674

Supplier is SME?

No

Supplier is VCSE?

No

Additional details

Oseltamivir Capsules (30 mg, 45 mg and 75 mg) for the Treatment of Patients Aged 1 Year and Over

Oseltamivir Suspension for the Treatment of Patients Aged 1 Year and Under

Oseltamivir Phosphate Powder (Active Pharmaceutical Ingredient (API)) Used for the Manufacture of a Solution
for Patients Aged 1 Year and Under

About the buyer

Address

2nd Floor Rutland House
Runcorn
WA7 2ES
England

Email

John.Cook@dh.gsi.gov.uk